Pharmacy to Dose: The Critical Care Podcast cover image

Heart Failure: Part I

Pharmacy to Dose: The Critical Care Podcast

00:00

SGLT2 Inhibitors - Are They Going Around on That Foreman?

The SGLT2 inhibitors are kind of, are they going around on that foreman where I'm going to be seeing these studied in everything? Because boy, every kind of disease state or intervention that they get studied in, they seem to have some sort of positive outcome with it. One of them is FDA approved just in CKD alone. You know, we'd say if you gain two pounds overnight or five pounds in a week, that's when you kind of want to think about starting it.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app